Compare INVE & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INVE | NTRB |
|---|---|---|
| Founded | 1990 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer peripheral equipment | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 65.1M | 72.6M |
| IPO Year | 1997 | 2019 |
| Metric | INVE | NTRB |
|---|---|---|
| Price | $2.61 | $6.80 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $5.50 | N/A |
| AVG Volume (30 Days) | ★ 159.3K | 60.9K |
| Earning Date | 05-13-2026 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $60,219,000.00 | $2,036,651.00 |
| Revenue This Year | $22.10 | $30.17 |
| Revenue Next Year | $20.74 | $3,394.36 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 7.21 | N/A |
| 52 Week Low | $2.42 | $2.80 |
| 52 Week High | $5.30 | $8.63 |
| Indicator | INVE | NTRB |
|---|---|---|
| Relative Strength Index (RSI) | 37.90 | 77.57 |
| Support Level | $2.46 | $4.18 |
| Resistance Level | $2.79 | N/A |
| Average True Range (ATR) | 0.10 | 0.61 |
| MACD | -0.02 | 0.18 |
| Stochastic Oscillator | 10.59 | 92.04 |
Identiv Inc develops specialty radio-frequency identification (RFID) and Internet of Things It (IoT) solutions that address customers' challenges and create new opportunities for them through the digitization and enhanced connectivity to the IoT. It designs, produces, and sells RFID and Bluetooth Low Energy (BLE) enabled devices, RFID inlays, tags, and labels that can be applied or incorporated into physical objects, providing them with a digital identity and the ability for customers to track, monitor, authenticate, and engage with consumers. Its IoT Business segment develops, manufactures, and supplies specialty IoT solutions tailored for the healthcare, logistics, smart packaging industries and other high-value end markets.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. Company operates in two reportable segments namely, Sales of Goods and Services. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.